In a paper published by “Science Today” journal reveals the significance of NAD+ in protecting cells from DNA damage. NAD+ is a metabolite that plays the role of a regulator in protein-protein interaction during DNA repair mechanism. The scientists treated the mice with a booster or precursor molecule, i.e. NMN, for NAD+, which improved the DNA repair mechanism. They aim at starting human trial within six months. If the trial becomes successful, the researchers claim its availability in market within the next 4-5 years. The companies that would endorse the drug are MetroBiotech NSW and MetroBiotech International.
University College London (UCL) Press has declared its hosting partnership with ScienceOpen with an intension to enhance its visibility as well as context of its content by implementing the full-text hosting services of ScienceOpen. It is aiming at hosting all its 8 journals on the ScienceOpen discovery platform and integrating with its research network to […]
Manchester University Press and Sheridan PubFactory are jointly working on a web hosting platform to host all the books and journals of Manchester University Press. Here Manchester University Press can directly control and manage the growth of their publishing program. José Fossi, VP of Client Services for PubFactory said, “We are excited to add Manchester […]
A group of science advocacy groups have expressed concerns regarding weakening of the nation’s science and engineering base due to the ban imposed by the U.S. government on immigrants from eight countries. Over 80 organizations have already written to the president Donald Trump regarding the negative impact that can already be seen due to the […]